Sep 20, 2019
Pharmefex LLC and Beck Life Sciences LLC, a leading Engineering, Procurement, and Construction firm, are pleased to announce the formation of a strategic collaboration. “This is an exciting time to be in the life sciences industry. Through our partnership with Pharmefex, we can broaden our experience, strengthen our relationships within the industry, and continue to innovate for our clients,” said Steve Springer, Director of Life Sciences at Beck. “The relationship with Beck enables us to offer a more extensive portfolio of services to our clients while remaining 100% focused on our mission of being the premier provider of CMC consulting expertise for biologics and cell therapy products,” said Ali Siahpush, President of Pharmefex. Pharmefex provides technical, CMC, and strategic support to streamline development and commercialization of biologics and cell therapy products worldwide. As part of this agreement, Beck Life Sciences will be able to extend its broad expertise and unmatched technologies to Pharmefex clients worldwide. Pharmefex will, in turn, make available it’s extensive experience and network of biologics and cell therapy expertise to Beck Life Sciences’ clients worldwide.